Advanced methodologies for cocrystal synthesis

Abstract Pharmaceutical cocrystals are multicomponent systems composed of two or more molecules and held together by H‐bonding. Currently, cocrystals provide exciting opportunities in the pharmaceutical industry for the development and manufacturing of new medicines by improving poor physical properties of Active Pharmaceutical Ingredients (APIs) such as processability, solubility, stability and bioavailability. According to the recent reclassification, cocrystals are considered as drug polymorph rather a new API which has a significant impact on drug development, regulatory submissions and intellectual property protection. This review summarizes recent trends and advances in synthesis, manufacturing and scale – up of cocrystals. The operational principles of several cocrystals manufacturing technologies are discussed including their advantages and disadvantages in terms of crystal quality, purity stability, throughput and limitations in large scale production. Graphical abstract Figure. No Caption available.

[1]  Henrique A. Matos,et al.  Insight into the Mechanisms of Cocrystallization of Pharmaceuticals in Supercritical Solvents , 2015 .

[2]  Thomas Rades,et al.  High-shear granulation as a manufacturing method for cocrystal granules. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[4]  T. Friščić,et al.  Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding. , 2007, Molecular pharmaceutics.

[5]  R. Tan,et al.  Dimorphs of a 1 : 1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph , 2009 .

[6]  E. Cranston,et al.  Optimization of Spray Drying Conditions for Yield, Particle Size and Biological Activity of Thermally Stable Viral Vectors , 2016, Pharmaceutical Research.

[7]  A. Cabañas,et al.  Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO2 as an antisolvent , 2016 .

[8]  Min-Jeong Lee,et al.  Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  T. Friščić,et al.  Control and interconversion of cocrystal stoichiometry in grinding: stepwise mechanism for the formation of a hydrogen-bonded cocrystal , 2009 .

[10]  A. Cabañas,et al.  Preparation of pharmaceutical co-crystals through sustainable processes using supercritical carbon dioxide: a review , 2016 .

[11]  R. Pinal,et al.  Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. , 2014, Journal of pharmaceutical sciences.

[12]  Christoph A. Merten,et al.  Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics. , 2016, Lab on a chip.

[13]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[14]  William Jones,et al.  Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.

[15]  Dennis Douroumis,et al.  Hot-Melt Extrusion: Pharmaceutical Applications , 2012 .

[16]  T. Friščić,et al.  Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. , 2006, Angewandte Chemie.

[17]  A. Beatty,et al.  A high-yielding supramolecular reaction. , 2002, Journal of the American Chemical Society.

[18]  J. Ketolainen,et al.  Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal , 2013, Pharmaceutical development and technology.

[19]  L. MacGillivray,et al.  Preparation and reactivity of nanocrystalline cocrystals formed via sonocrystallization. , 2007, Journal of the American Chemical Society.

[20]  Naír Rodríguez-Hornedo,et al.  Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase , 2006, Pharmaceutical Research.

[21]  Henrique A. Matos,et al.  Tuning physicochemical properties of theophylline by cocrystallization using the supercritical fluid enhanced atomization technique , 2014 .

[22]  Paul J. A. Kenis,et al.  Microfluidic Approach to Cocrystal Screening of Pharmaceutical Parent Compounds , 2012 .

[23]  Leonard J. Barbour,et al.  Concepts and Nomenclature in Chemical Crystallography , 2012 .

[24]  Andrew D. Bond,et al.  What is a co-crystal? , 2007 .

[25]  V. Stepanov,et al.  Production and Sensitivity Evaluation of Nanocrystalline RDX‐based Explosive Compositions , 2011 .

[26]  Mohammed Maniruzzaman,et al.  Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing , 2014 .

[27]  M. Senna,et al.  Hallmarks of mechanochemistry: from nanoparticles to technology. , 2013, Chemical Society reviews.

[28]  D. Braga,et al.  Mechanochemical preparation of co-crystals. , 2013, Chemical Society reviews.

[29]  S. Childs,et al.  The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome , 2009 .

[31]  Charles E. Martin,et al.  Pharmaceutical Applications of Hot-Melt Extrusion: Part I , 2007, Drug development and industrial pharmacy.

[32]  Alejandro Sosnik,et al.  Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. , 2015, Advances in colloid and interface science.

[33]  William Jones,et al.  Cocrystallization by Freeze-Drying: Preparation of Novel Multicomponent Crystal Forms , 2013 .

[34]  Min-Jeong Lee,et al.  Anti-solvent co-crystallization of carbamazepine and saccharin. , 2013, International journal of pharmaceutics.

[35]  William Jones,et al.  Selective polymorph transformation via solvent-drop grinding. , 2005, Chemical communications.

[36]  P. York,et al.  Cocrystalization and Simultaneous Agglomeration Using Hot Melt Extrusion , 2010, Pharmaceutical Research.

[37]  A. Vaughan,et al.  Preparation of nanoparticles , 2016 .

[38]  Naír Rodríguez-Hornedo,et al.  Factors that influence the spontaneous formation of pharmaceutical cocrystals by simply mixing solid reactants , 2009 .

[39]  Abhishek Singh,et al.  Spray drying formulation of amorphous solid dispersions. , 2016, Advanced drug delivery reviews.

[40]  K. Terada,et al.  Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization , 2008 .

[41]  David R. Weyna,et al.  Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .

[42]  Christer B. Aakeröy,et al.  Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. , 2009, Journal of the American Chemical Society.

[43]  I. Paul,et al.  Interconversion by hydrogen transfer of unsymmetrically substituted quinhydrones in the solid state. Crystal structure of the 1:2 complex of 2,5-dimethylquinone with hydroquinone , 1984 .

[44]  Orn Almarsson,et al.  Performance comparison of a co-crystal of carbamazepine with marketed product. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  T. Persoons,et al.  Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Michael J. Zaworotko,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2003, Chemical communications.

[47]  K. Nagapudi,et al.  Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. , 2010, Journal of pharmaceutical sciences.

[48]  Elizabeth M. Horstman,et al.  Crystallization Optimization of Pharmaceutical Solid Forms with X-ray Compatible Microfluidic Platforms , 2015 .

[49]  Michael J. Zaworotko,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .

[50]  Peter York,et al.  Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[51]  Gerd Kaupp,et al.  Organic Solid-State Reactions with 100% Yield , 2005 .

[52]  F. Emmerling,et al.  Polymorphism of Mechanochemically Synthesized Cocrystals: A Case Study , 2016 .

[53]  Ning Shan,et al.  The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.

[54]  D. Ende,et al.  Development and Scale-Up of Cocrystals Using Resonant Acoustic Mixing , 2014 .

[55]  N. Scoutaris,et al.  Jet dispensing as a high throughput method for rapid screening and manufacturing of cocrystals , 2016 .

[56]  D. Douroumis,et al.  Continuous Cocrystallization for Dissolution Rate Optimization of a Poorly Water-Soluble Drug , 2014 .

[57]  Arnaud Erriguible,et al.  Challenge of the supercritical antisolvent technique SAS to prepare cocrystal-pure powders of naproxen-nicotinamide , 2016 .

[58]  A. Nokhodchi,et al.  Theophylline Cocrystals Prepared by Spray Drying: Physicochemical Properties and Aerosolization Performance , 2013, AAPS PharmSciTech.

[59]  Kenneth I. Hardcastle,et al.  Cocrystals of Piroxicam with Carboxylic Acids , 2007 .

[60]  Henrique A. Matos,et al.  Single-Step Co-Crystallization and Lipid Dispersion by Supercritical Enhanced Atomization , 2013 .

[61]  H. Muhr,et al.  Continuous formation of submicron energetic particles by the flash-evaporation technique , 2012 .

[62]  T. Rades,et al.  Formation Kinetics and Stability of Carbamazepine―Nicotinamide Cocrystals Prepared by Mechanical Activation , 2009 .

[63]  S. Velaga,et al.  Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.

[64]  Sitaram P. Velaga,et al.  Formation of Cocrystals from Stoichiometric Solutions of Incongruently Saturating Systems by Spray Drying , 2010 .

[65]  F. Emmerling,et al.  Mechanochemical synthesis and structural characterisation of a theophylline-benzoic acid cocrystal (1 : 1) , 2012 .

[66]  Ram B. Gupta,et al.  Formation of itraconazole/L-malic acid cocrystals by gas antisolvent cocrystallization , 2013 .

[67]  David S. Jones,et al.  Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization. , 2016, Molecular pharmaceutics.

[68]  William Jones,et al.  Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding , 2009 .

[69]  A. Healy,et al.  Cocrystal habit engineering to improve drug dissolution and alter derived powder properties , 2016, The Journal of pharmacy and pharmacology.

[70]  K. Nagapudi,et al.  Application of Twin Screw Extrusion in the Manufacture of Cocrystals, Part I: Four Case Studies , 2011, Pharmaceutics.

[71]  Hak-Kim Chan,et al.  Amorphous powders for inhalation drug delivery. , 2016, Advanced drug delivery reviews.

[72]  Chuanbin Wu,et al.  Improving the Chemical Stability of Amorphous Solid Dispersion with Cocrystal Technique by Hot Melt Extrusion , 2011, Pharmaceutical Research.

[73]  Min-Jeong Lee,et al.  In Situ Monitoring of Antisolvent Cocrystallization by Combining Near-Infrared and Raman Spectroscopies , 2015 .

[74]  Scott L. Childs,et al.  Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability. , 2013, Molecular pharmaceutics.

[75]  A. Kelly,et al.  Monitoring ibuprofen-nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool. , 2012, International journal of pharmaceutics.

[76]  K. Cal,et al.  Spray drying technique. I: Hardware and process parameters. , 2010, Journal of pharmaceutical sciences.

[77]  Tomohiro Sato,et al.  Molecular recognition in solid-state crystallization: colored chiral adduct formations of 1,1'-bi-2-naphthol derivatives and benzoquinone with a third component. , 2002, Chirality.

[78]  A K Uguz,et al.  Screening applications in drug discovery based on microfluidic technology. , 2016, Biomicrofluidics.

[79]  Gautam R. Desiraju,et al.  Crystal and co-crystal , 2003 .

[80]  H. Brittain.  Pharmaceutical cocrystals: the coming wave of new drug substances. , 2013, Journal of pharmaceutical sciences.

[81]  G. Espinosa-Pérez,et al.  Cocrystals Definitions , 2007 .

[82]  Philip F. Pagoria,et al.  High Power Explosive with Good Sensitivity: A 2:1 Cocrystal of CL-20:HMX , 2012 .

[83]  A. Healy,et al.  Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties. , 2015, Journal of pharmaceutical sciences.

[84]  Iain D. H. Oswald,et al.  Crystal engineering of energetic materials: Co-crystals of CL-20 , 2012 .

[85]  L. Fábián,et al.  Powder X-ray diffraction as an emerging method to structurally characterize organic solids. , 2007, Organic letters.

[86]  William Jones,et al.  Achieving Polymorphic and Stoichiometric Diversity in Cocrystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding , 2005 .

[87]  Dennis Douroumis,et al.  Continuous Manufacturing of High Quality Pharmaceutical Cocrystals Integrated with Process Analytical Tools for In-Line Process Control , 2016 .

[88]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[89]  Eric Doelker,et al.  Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs , 1994 .

[90]  Christer B. Aakeröy,et al.  Building co-crystals with molecular sense and supramolecular sensibility , 2005 .

[91]  C. Strachan,et al.  Investigation of the Formation Process of Two Piracetam Cocrystals during Grinding , 2011, Pharmaceutics.

[92]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[93]  D. Peabody,et al.  Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. , 2016, Molecular pharmaceutics.

[94]  Gargi Mukherjee,et al.  Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .

[95]  Ram B. Gupta,et al.  Formation of Itraconazole–Succinic Acid Cocrystals by Gas Antisolvent Cocrystallization , 2012, AAPS PharmSciTech.

[96]  Michael A Repka,et al.  The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[97]  Ahmad Y. Sheikh,et al.  Scalable solution cocrystallization: case of carbamazepine-nicotinamide I , 2009 .

[98]  A. Bak,et al.  Two Novel Pharmaceutical Cocrystals of a Development Compound – Screening, Scale-up, and Characterization , 2012 .

[99]  Steven A. Ross,et al.  Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies. , 2016, Chemical communications.

[100]  Martin A. Wahl,et al.  Simultaneous Formation and Micronization of Pharmaceutical Cocrystals by Rapid Expansion of Supercritical Solutions (RESS) , 2014, Pharmaceutical Research.

[101]  D. Spitzer,et al.  Continuous engineering of nano-cocrystals for medical and energetic applications , 2014, Scientific Reports.

[102]  K. Nagapudi,et al.  Application of twin screw extrusion to the manufacture of cocrystals: scale-up of AMG 517-sorbic acid cocrystal production. , 2014, Faraday discussions.

[103]  A. Nangia,et al.  Binary and ternary cocrystals of sulfa drug acetazolamide with pyridine carboxamides and cyclic amides , 2016, IUCrJ.

[104]  S. Laugier,et al.  Naproxen–nicotinamide cocrystals produced by CO2 antisolvent , 2013 .

[105]  M. Eddleston,et al.  Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials. , 2014, Faraday discussions.

[106]  A. Bansal,et al.  Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[107]  Luis Padrela,et al.  Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[108]  Iain D. H. Oswald,et al.  From discovery to scale-up: alpha-lipoic acid : nicotinamide co-crystals in a continuous oscillatory baffled crystalliser , 2014 .

[109]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[110]  E. Squillante,et al.  Formulation development of Carbamazepine–Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process , 2011 .

[111]  D. Braga,et al.  Making crystals from crystals: three solvent-free routes to the hydrogen bonded co-crystal between 1,1′-di-pyridyl-ferrocene and anthranilic acid , 2007 .

[112]  S. Reutzel,et al.  Hydrogen Bond Directed Cocrystallization and Molecular Recognition Properties of Acyclic Imides , 1991 .

[113]  Min-Jeong Lee,et al.  Combined anti-solvent and cooling method of manufacturing indomethacin–saccharin (IMC–SAC) co-crystal powders , 2014 .

[114]  J. Jay Liu,et al.  Understanding the Formation of Indomethacin–Saccharin Cocrystals by Anti-Solvent Crystallization , 2013 .

[115]  Jonathan W Steed,et al.  The role of co-crystals in pharmaceutical design. , 2013, Trends in pharmacological sciences.

[116]  Jack D. Dunitz,et al.  Crystal and co-crystal: A second opinion , 2003 .